Perspectives and progress in development of breast cancer chemopreventive drugs.

Progress in clinical and biological research

Volumn 396, Issue , 1997, Pages 159-183

  Kelloff, G J ^a   Boone, C W ^a   Crowell, J A ^a   Nayfield, S G ^a   Hawk, E T ^a   Steele, V E ^a   Lubet, R A ^a   Sigman, C C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; FENRETINIDE; PRASTERONE; TAMOXIFEN; TUMOR MARKER;

BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; REVIEW; RISK FACTOR;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DEHYDROEPIANDROSTERONE; ESTROGEN ANTAGONISTS; FEMALE; FENRETINIDE; HUMANS; RISK FACTORS; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0030642168     PISSN: 03617742     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (159)